| Angela Faye Stogsdill-hurt, OTR/L | |
|
305 Langdon St, Somerset, KY 42503-2750 | |
| (606) 678-3308 | |
| Not Available |
| Full Name | Angela Faye Stogsdill-hurt |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 305 Langdon St, Somerset, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366803991 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | R5683 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela Faye Stogsdill-hurt, OTR/L 3496 Cannonball Rd, Somerset, KY 42501-5424 Ph: (606) 492-9816 | Angela Faye Stogsdill-hurt, OTR/L 305 Langdon St, Somerset, KY 42503-2750 Ph: (606) 678-3308 |
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
Researchers published a study on the expression and functional analyses of a neutralizing mAb with identical variable domains but different constant HCs, representing IgG1-4.
AIDS Healthcare Foundation today commended the United States Congress for showing a strong bipartisan commitment to AIDS in passing the fiscal year 2011 budget earlier this afternoon, a budget that despite severe cost-cutting mentality in Washington, included a $48 million overall increase in the $883 million allocated for the nation's AIDS Drug Assistance Program, a network of federal and state funded programs that provide life-saving HIV treatments to low income, uninsured, and underinsured individuals living with HIV/AIDS nationwide.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced positive clinical data with the Company's IMGN901 (lorvotuzumab mertansine) product candidate as featured in an oral presentation at the ASCO 2011 Annual Meeting in Chicago.
› Verified 7 days ago
April Lasha Bussell, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 175 Medpark Dr, Somerset, KY 42503 Phone: 606-679-1761 | |
Mrs. Trena Schultz, OTR/L, CHT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 175 Medpark Dr, Somerset, KY 42503 Phone: 606-679-1761 Fax: 606-678-0971 | |
Mrs. Megan M Angel, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 303 Second St, Somerset, KY 42501 Phone: 606-679-1166 | |
Alicia Garland, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 555 Bourne Ave, Somerset, KY 42501 Phone: 606-679-7421 | |
Mrs. Nicole L Blevins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 353 Bogle St, Suite 203, Somerset, KY 42503 Phone: 606-679-1761 Fax: 606-678-0971 | |
Mrs. Leslie Anne Preston, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 555 Bourne Ave, Somerset, KY 42501 Phone: 606-679-7421 | |
Keirstyn Shaye Morton, OTD, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 175 Medpark Dr, Somerset, KY 42503 Phone: 606-679-1761 Fax: 606-678-0971 |